Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D04RKW
|
|||
Former ID |
DIB005262
|
|||
Drug Name |
7-methylxanthine
|
|||
Synonyms |
Adenosine receptor antagonist (myopia), Trier; 7-MX
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Myopia [ICD-11: 9D00.0; ICD-10: H52.1] | Phase 2 | [1] | |
Company |
Trier Research Laboratories
|
|||
Structure |
Download2D MOL |
|||
Formula |
C6H6N4O2
|
|||
Canonical SMILES |
CN1C=NC2=C1C(=O)NC(=O)N2
|
|||
InChI |
1S/C6H6N4O2/c1-10-2-7-4-3(10)5(11)9-6(12)8-4/h2H,1H3,(H2,8,9,11,12)
|
|||
InChIKey |
PFWLFWPASULGAN-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 552-62-5
|
|||
PubChem Compound ID | ||||
ChEBI ID |
CHEBI:48991
|
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT00263471) Myopia Progression and the Effect of 7-Methylxanthine. U.S. National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.